TE_92
Basic information Differential Expression Stage analysis Survival analysis Correlation analysisTE family | THE1A |
---|---|
TE superfamily | MaLR |
TE class | LTR |
Gene | LINC02606, - |
Class | Chimeric, Intergenic |
Coding | Non-coding, Other |
Tumor-specific score | 5.84 |
Counts of samples | TCGA_tumor:56; TCGA_normal:0; GTEx:10 |
TSS | chr1(-):9451217 |
Transcript isoforms
Transcript_ID | Gene | Class | Coding | ORF | Position |
---|---|---|---|---|---|
teRNA_92.11 | - | Intergenic | Non-coding | Non-coding | chr1(-):9440497,9440517,9441809,9441930,9444232,9450250,9451140,9451218 |
teRNA_92.12 | LINC02606 | Chimeric | Other | MKQSVFLKIYENGYIQTMEYYSVEMSYQAVNKHGGKKSSPFESQDLPTDPSSTSEMMLRQAEAHSPDCLQYRHFFRPLHLPLLTAPSGQARGLPVLILQAENIARNREVTLGSLASSQKTFSNETKEKKFQFVGRTLVSIGITKPVRRPSPDAGALILDFSAFRTVRNTFLFIMNYLVPGILLEQHKTG* | chr1(-):9427361,9427381,9428922,9440517,9441809,9441930,9444232,9444437,9444943,9449414,9450066,9450250,9451140,9451218 |
teRNA_92.13 | - | Intergenic | Non-coding | Non-coding | chr1(-):9428373,9428393,9441809,9441930,9444943,9449414,9450066,9450250,9451140,9451218 |
teRNA_92.14 | - | Intergenic | Non-coding | Non-coding | chr1(-):9449331,9449351,9449718,9449794,9450066,9450250,9451140,9451218 |
teRNA_92.15 | - | Intergenic | Non-coding | Non-coding | chr1(-):9440497,9440517,9441809,9441930,9444943,9445041,9450066,9450250,9451140,9451218 |
teRNA_92.16 | - | Intergenic | Non-coding | Non-coding | chr1(-):9445021,9445041,9450066,9450250,9451140,9451218 |
teRNA_92.17 | - | Intergenic | Non-coding | Non-coding | chr1(-):9449331,9449351,9449718,9450250,9451140,9451218 |
teRNA_92.18 | LINC02606 | Chimeric | Non-coding | Non-coding | chr1(-):9427361,9427381,9450066,9450250,9451140,9451218 |
teRNA_92.19 | - | Intergenic | Non-coding | Non-coding | chr1(-):9437851,9437871,9450066,9450250,9451140,9451218 |
teRNA_92.20 | - | Intergenic | Non-coding | Non-coding | chr1(-):9440497,9440517,9441809,9441930,9444232,9444437,9444943,9445041,9450066,9450250,9451140,9451218 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.